FineVision HP (POD F GF)
The FINEVISION HP intraocular lens (IOL) stands out as a pioneering advancement in the field of ophthalmology, offering a wide range of features that elevate it above conventional lenses. As a biconvex aspheric trifocal IOL, it is meticulously designed with an anterior diffractive surface to ensure optimal vision across multiple distances. The lens provides two addition powers of 3.5 diopters (D) and 1.75 D at the IOL plane, which allow patients to enjoy seamless, continuous vision, enabling them to perform tasks effectively at near, intermediate, and far distances. This versatility is particularly beneficial for individuals seeking greater independence from glasses in their everyday activities.
One of the defining characteristics of the FINEVISION HP is its convoluted and apodized design. The lens’s aspheric surface, combined with its unique engineering, facilitates a gradual decrease in step height from the center to the periphery. This results in a variable redistribution of energy between far and near vision depending on the pupil diameter, which enhances the lens’s adaptability to different lighting conditions and visual demands. The central zone of the lens, measuring 1.16 mm, allows for a theoretically maximum kappa angle of 580 microns, further contributing to its precision and performance.
Additionally, FINEVISION HP is manufactured from a patented glistening-free hydrophobic material, which ensures durability and long-lasting performance. The material’s glistening-free nature is crucial as it prevents the formation of micro-vacuoles that could affect visual quality. This advanced material is also equipped with UV and blue light filtration, offering protection from harmful light exposure while maintaining a natural yellow color that mimics the eye’s natural lens. These protective features not only safeguard the eye but also contribute to the overall visual comfort of patients, particularly those exposed to bright or varying light environments.
In terms of stability, the FINEVISION HP is designed with a double C-loop structure that enhances its placement and stability within the eye. This robust design contributes to better centration and reduces the likelihood of postoperative complications, ensuring that the lens remains securely positioned, even over the long term. The lens’s stability and superior design translate into a high level of patient satisfaction, with up to 95% of users experiencing independence from spectacles after implantation.
Confidence, reliability, and reassurance are key attributes associated with the FINEVISION HP, as it is backed by extensive clinical data, positioning it as a trusted choice in the premium IOL market. It has the distinction of being the world’s first trifocal IOL, a groundbreaking innovation in the field. With over one million units sold globally, the FINEVISION HP has established itself as the gold standard for premium implants, providing surgeons and patients alike with a trusted solution for achieving superior visual outcomes. Its long-term clinical data reinforces its reliability and effectiveness, making it a preferred choice for those seeking the latest in vision correction technology.
